Peripartum cardiomyopathy
Learn about Peripartum cardiomyopathy, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Postpartum cardiomyopathy
The sources compiled here do not cover: diagnosis, treatment, prevention. Ask the treating doctor about these.
What it is
From: Orphanet
Peripartum cardiomyopathy (PPCM) is an idiopathic, potentially fatal form of dilated cardiomyopathy that develops during the final month of pregnancy or within five months after delivery.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal T-wave · Frequent (79-30%)
- An abnormality of the T wave on the electrocardiogram, which mainly represents the repolarization of the ventricles.
- Congestive heart failure · Frequent (79-30%)
- The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction.
- Dilated cardiomyopathy · Frequent (79-30%)
- Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular dilatation and left ventricular systolic dysfunction in the absence of abnormal loading conditions (hypertension, valve disease) or coronary artery disease sufficient to cause global systolic impairment. Right ventricular dilation and dysfunction may be present but are not necessary for the diagnosis.
- Dyspnea · Frequent (79-30%)
- Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.
- Elevated jugular venous pressure · Frequent (79-30%)
- Increased jugular venous pressure.
- Exertional dyspnea · Frequent (79-30%)
- Perceived difficulty to breathe that occurs with exercise or exertion and improves with rest.
- Fatigue · Frequent (79-30%)
- A subjective feeling of tiredness characterized by a lack of energy and motivation.
- Hypertension · Frequent (79-30%)
- The presence of chronic increased pressure in the systemic arterial system.
- Left ventricular hypertrophy · Frequent (79-30%)
- Enlargement or increased size of the heart left ventricle.
- Left ventricular systolic dysfunction · Frequent (79-30%)
- Abnormality of left ventricular contraction, often defined operationally as an ejection fraction of less than 40 percent.
- Orthopnea · Frequent (79-30%)
- A sensation of breathlessness in the recumbent position, relieved by sitting or standing.
- Palpitations · Frequent (79-30%)
- A sensation that the heart is pounding or racing, which is a non-specific sign but may be a manifestation of arrhythmia.
- Pedal edema · Frequent (79-30%)
- An abnormal accumulation of excess fluid in the lower extremity resulting in swelling of the feet and extending upward to the lower leg.
- Reduced left ventricular ejection fraction · Frequent (79-30%)
- A diminution of the volumetric fraction of blood pumped out of the ventricle with each cardiac cycle.
Other findings in the same source
From: Orphanet
Additional reported features include Sinus tachycardia (Frequent (79-30%)); Tachycardia (Frequent (79-30%)); Abnormal atrioventricular valve morphology (Occasional (29-5%)); Abnormal cardiac atrium morphology (Occasional (29-5%)); Chest pain (Occasional (29-5%)); Crackles (Occasional (29-5%)); Heart murmur (Occasional (29-5%)); Increased serum interferon-gamma level (Occasional (29-5%)); Left atrial enlargement (Occasional (29-5%)); Mitral regurgitation (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adult
Inheritance in the source
From: Orphanet
Unknown
Frequency and the population described
From: Orphanet
Prevalence at birth: 6-9 / 10 000; Singapore; Value and class. Prevalence at birth: 1-9 / 100 000; Japan; Value and class. Prevalence at birth: >1 / 1000; Haiti; Value and class. Prevalence at birth: >1 / 1000; South Africa; Value and class.
Which doctor should you see?
The suggested department for discussing Peripartum cardiomyopathy is Cardiology, with a cardiologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Is the main concern heart structure, rhythm, circulation or another cause?
- Which symptoms should change the timing of follow-up?
- How would a proposed investigation change the care plan?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Peripartum cardiomyopathy. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a cardiologist. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Peripartum cardiomyopathy — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1828.